203 related articles for article (PubMed ID: 30977626)
1. Protease Degradation of Protein Coronas and Its Impact on Cancer Cells and Drug Payload Release.
Rodriguez-Quijada C; de Puig H; Sánchez-Purrà M; Yelleswarapu C; Evans JJ; Celli JP; Hamad-Schifferli K
ACS Appl Mater Interfaces; 2019 Apr; 11(16):14588-14596. PubMed ID: 30977626
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of the Enzymatic Degradation of Protein Corona and Evaluating the Accompanying Cytotoxicity of Nanoparticles.
Ma Z; Bai J; Jiang X
ACS Appl Mater Interfaces; 2015 Aug; 7(32):17614-22. PubMed ID: 26200209
[TBL] [Abstract][Full Text] [Related]
3. Protein Corona Formed from Different Blood Plasma Proteins Affects the Colloidal Stability of Nanoparticles Differently.
Ho YT; Azman N'; Loh FWY; Ong GKT; Engudar G; Kriz SA; Kah JCY
Bioconjug Chem; 2018 Nov; 29(11):3923-3934. PubMed ID: 30347973
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody-functionalized multilayered particles: targeting cancer cells in the presence of protein coronas.
Dai Q; Yan Y; Ang CS; Kempe K; Kamphuis MM; Dodds SJ; Caruso F
ACS Nano; 2015 Mar; 9(3):2876-85. PubMed ID: 25712076
[TBL] [Abstract][Full Text] [Related]
5. Component-Specific Analysis of Plasma Protein Corona Formation on Gold Nanoparticles Using Multiplexed Surface Plasmon Resonance.
Patra A; Ding T; Engudar G; Wang Y; Dykas MM; Liedberg B; Kah JC; Venkatesan T; Drum CL
Small; 2016 Mar; 12(9):1174-82. PubMed ID: 26455731
[TBL] [Abstract][Full Text] [Related]
6. Cascading Effects of Nanoparticle Coatings: Surface Functionalization Dictates the Assemblage of Complexed Proteins and Subsequent Interaction with Model Cell Membranes.
Melby ES; Lohse SE; Park JE; Vartanian AM; Putans RA; Abbott HB; Hamers RJ; Murphy CJ; Pedersen JA
ACS Nano; 2017 Jun; 11(6):5489-5499. PubMed ID: 28482159
[TBL] [Abstract][Full Text] [Related]
7. Protein Corona Formation on Colloidal Polymeric Nanoparticles and Polymeric Nanogels: Impact on Cellular Uptake, Toxicity, Immunogenicity, and Drug Release Properties.
Obst K; Yealland G; Balzus B; Miceli E; Dimde M; Weise C; Eravci M; Bodmeier R; Haag R; Calderón M; Charbaji N; Hedtrich S
Biomacromolecules; 2017 Jun; 18(6):1762-1771. PubMed ID: 28511014
[TBL] [Abstract][Full Text] [Related]
8. Interaction of gold and silver nanoparticles with human plasma: Analysis of protein corona reveals specific binding patterns.
Lai W; Wang Q; Li L; Hu Z; Chen J; Fang Q
Colloids Surf B Biointerfaces; 2017 Apr; 152():317-325. PubMed ID: 28131092
[TBL] [Abstract][Full Text] [Related]
9. Composition of Intracellular Protein Corona around Nanoparticles during Internalization.
Wang C; Chen B; He M; Hu B
ACS Nano; 2021 Feb; 15(2):3108-3122. PubMed ID: 33570905
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of cell uptake, inflammatory potential and protein corona effects with gold nanoparticles.
Li Y; Monteiro-Riviere NA
Nanomedicine (Lond); 2016 Dec; 11(24):3185-3203. PubMed ID: 27882809
[TBL] [Abstract][Full Text] [Related]
11. Protein corona modulation of hepatocyte uptake and molecular mechanisms of gold nanoparticle toxicity.
Choi K; Riviere JE; Monteiro-Riviere NA
Nanotoxicology; 2017 Feb; 11(1):64-75. PubMed ID: 27885867
[TBL] [Abstract][Full Text] [Related]
12. Protein corona: implications for nanoparticle interactions with pulmonary cells.
Konduru NV; Molina RM; Swami A; Damiani F; Pyrgiotakis G; Lin P; Andreozzi P; Donaghey TC; Demokritou P; Krol S; Kreyling W; Brain JD
Part Fibre Toxicol; 2017 Oct; 14(1):42. PubMed ID: 29084556
[TBL] [Abstract][Full Text] [Related]
13. Exploiting the novel properties of protein coronas: emerging applications in nanomedicine.
Hamad-Schifferli K
Nanomedicine (Lond); 2015 May; 10(10):1663-74. PubMed ID: 26008198
[TBL] [Abstract][Full Text] [Related]
14. Optimizing the properties of the protein corona surrounding nanoparticles for tuning payload release.
Cifuentes-Rius A; de Puig H; Kah JC; Borros S; Hamad-Schifferli K
ACS Nano; 2013 Nov; 7(11):10066-74. PubMed ID: 24128271
[TBL] [Abstract][Full Text] [Related]
15. Evidence of protein coronas around soft nanoparticles regardless of the chemical nature of the outer surface: structural features and biological consequences.
de Castro CE; Panico K; Stangherlin LM; Albuquerque LJC; A S Ribeiro C; da Silva MCC; Jäger E; Giacomelli FC
J Mater Chem B; 2021 Mar; 9(8):2073-2083. PubMed ID: 33594396
[TBL] [Abstract][Full Text] [Related]
16. How protein coronas determine the fate of engineered nanoparticles in biological environment.
Capjak I; Goreta SŠ; Jurašin DD; Vrček IV
Arh Hig Rada Toksikol; 2017 Dec; 68(4):245-253. PubMed ID: 29337683
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the influence of protein corona composition on gold nanoparticle bioactivity using machine learning approaches.
Papa E; Doucet JP; Sangion A; Doucet-Panaye A
SAR QSAR Environ Res; 2016 Jul; 27(7):521-38. PubMed ID: 27329717
[TBL] [Abstract][Full Text] [Related]
18. Corona Composition Can Affect the Mechanisms Cells Use to Internalize Nanoparticles.
Francia V; Yang K; Deville S; Reker-Smit C; Nelissen I; Salvati A
ACS Nano; 2019 Oct; 13(10):11107-11121. PubMed ID: 31525954
[TBL] [Abstract][Full Text] [Related]
19. Protein-gold nanoparticle interactions and their possible impact on biomedical applications.
Liu J; Peng Q
Acta Biomater; 2017 Jun; 55():13-27. PubMed ID: 28377307
[TBL] [Abstract][Full Text] [Related]
20. Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity.
Lee YK; Choi EJ; Webster TJ; Kim SH; Khang D
Int J Nanomedicine; 2015; 10():97-113. PubMed ID: 25565807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
